Real-world effectiveness and prognostic factors of platinum rechallenge in advanced urothelial cancer.

1.9 months; HR, 0.53; 95% CI, 0.28–1.01; p = 0.055) for prior platinum-based chemotherapy were numerically longer in the DDR-altered subgroup, though these differences did not reach statistical significance.

also in 111,027 other papers